MoneyWorks4Me

Ajanta Pharma informs about disclosure

09 Jun 2026 Evaluate
Ajanta Pharma has informed that it enclosed disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 08, 2026 for Aayush Agrawal, trustee Aayush Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1859.90
Dr. Reddys Labs. 1173.00
Cipla 1379.10
Lupin 2080.00
Zydus Lifesciences 1136.70
View more..